Home / Digestive tract and metabolism / Insulin Aspart
ATC A10AD05 · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-Acting
Insulin Aspart shortage
As of 2 Nov 2026, Insulin Aspart has a reported shortage in 1 of the 16 countries we track (Japan), covering 1 product from 1 company.
Countries1/16
Products1packs or presentations
Companies11 listed
Short since24 May 20242.4 years ago
Earliest returnnot givencompany estimate
Main reasonOther
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan1 product shortNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
Japan
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Novo Nordisk NOVO B · Nasdaq Copenhagen
Compared with similar medicines
ATC group A10AD · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-ActingAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | ノボラピッド注 フレックスタッチ | ノボノルディスクファーマ | 24 May 2024 | not given | Other |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.